Le Sserafim to perform at Singapore’s new Apex @ Expo venue in November

K-pop group Le Sserafim will perform at Singapore's newly opened Apex @ Expo on November 28, with the 9,000-capacity venue marking a significant booking for the facility.

MARKETS 2 MIN READ

Le Sserafim, the five-member K-pop girl group under Hybe subsidiary Source Music, will perform at Singapore's newly opened Apex @ Expo on November 28. The venue can accommodate up to 9,000 attendees.

The concert booking represents a vote of confidence in the new facility's capacity to host major music events. Apex @ Expo's selection as the venue for a top-tier K-pop act—one of a handful commanding ticket sales at this scale in Southeast Asia—suggests the operator has secured sufficient anchoring bookings to justify the venue's construction and operational costs.

Le Sserafim has built a measurable following in the region. The group's 2023 releases "Unforgiven" and "Perfect Night" charted across multiple Asian markets. Their latest album, Pureflow Pt 1, released in May, topped South Korea's Circle Album Chart. The band formed in 2022 under Hybe, the South Korean entertainment conglomerate behind BTS.

Ticket sales mechanics will roll in phases: official Fearnot members (via Weverse platform) access presales from August 4 at 12pm to 11:59pm SGT, followed by general sales commencing August 5 through Ticketmaster. The phased approach, common in K-pop ticketing, is designed to secure baseline revenue before opening inventory to broader audiences, reducing demand uncertainty.

The booking adds to a growing slate of international music events in Singapore's venue calendar. Whether the 9,000-seat capacity performs at breakeven or generates margin surplus for Apex @ Expo's operator depends on ticket pricing, production costs, and per-capita spend on ancillary services (food, merchandise). Industry standard for arena-scale music events targets 70-80% capacity to cover fixed costs; Le Sserafim's established fanbase in Singapore suggests the threshold is achievable.